HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
HARVARD BIOSCIENCE INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$8.09+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $36.62M
- P/E (TTM)
- –
- Dividend yield
- –
HARVARD BIOSCIENCE INC revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Instruments, Equipment, Software, and Accessories [Member] | $20.30M | $18.57M | $21.64M | $18.58M | $18.18M | $19.87M | $22.37M | $20.54M | $21.29M | $22.76M | $26.46M | $23.50M | 89.3% | +11.7% |
| Service, Maintenance, and Warranty Contracts [Member] | $2.42M | $2.19M | $2.10M | $2.01M | $2.27M | $1.91M | $2.19M | $1.43M | $1.81M | $1.75M | $1.70M | $1.86M | 10.7% | +6.6% |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $10.50M | $8.81M | $10.23M | $9.25M | $9.66M | $9.83M | $10.24M | $9.71M | $10.81M | $10.98M | $11.55M | $12.02M | 46.2% | +8.8% |
| EMEA [Member] | $6.78M | $6.47M | $7.48M | $6.61M | $6.59M | $6.03M | $8.56M | $6.62M | $6.60M | $6.62M | – | – | 29.8% | +3.0% |
| China | $3.08M | $2.81M | $3.64M | $2.15M | $2.45M | $2.73M | $3.15M | $2.64M | $3.25M | $4.26M | – | – | 13.5% | +25.5% |
| Asia, Other [Member] | $1.49M | $1.83M | $1.59M | $1.40M | $1.33M | $2.35M | $1.64M | $1.79M | $1.78M | $1.89M | – | – | 6.5% | +11.6% |
| Americas, Other [Member] | $878.00K | $847.00K | $791.00K | $1.19M | $422.00K | $829.00K | $961.00K | $1.21M | $663.00K | $761.00K | – | – | 3.9% | +108.1% |
| Rest of the World [Member] | – | – | – | – | – | – | – | $3.03M | $2.51M | $2.57M | $2.97M | $2.79M | – | – |
| Europe [Member] | – | – | – | – | – | – | – | $6.50M | $6.54M | $6.58M | $8.97M | $7.06M | – | – |
| Greater China [Member] | – | – | – | – | – | – | $2.87M | $2.73M | $3.25M | $4.38M | $4.66M | $3.49M | – | – |
From the segment and revenue-disaggregation notes of Harvard Bioscience's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.